NLRP3 Inflammasome Mechanisms in Autoimmune Diseases

The NLRP3 inflammasome is a cytosolic multiprotein complex central to innate immunity that senses a wide array of danger signals and orchestrates the proteolytic activation of caspase-1. Activated caspase-1 drives maturation and secretion of interleukin-1β (IL-1β) and interleukin-18 (IL-18) and initiates pyroptosis, an inflammatory form of programmed cell death. In autoimmune diseases such as rheumatoid arthritis, systemic lupus erythematosus, Hashimoto’s thyroiditis and lupus nephritis, dysregulated NLRP3 activation contributes to persistent inflammation, tissue injury and breach of self-tolerance. Pathogenic mechanisms include aberrant priming through toll-like receptors, ionic fluxes, mitochondrial dysfunction and impaired autophagy. Regulatory nodes such as deubiquitination and interactions with accessory proteins fine-tune NLRP3 stability and assembly. Emerging evidence highlights disease-specific triggers—calcium-sensing receptor signalling in arthritic joints, anti-dsDNA antibody-induced mitochondrial reactive oxygen species in lupus, or thyroid follicular cell ubiquitin dynamics in thyroiditis—that drive excessive inflammasome activity. Therapeutic strategies under investigation seek to block upstream activation signals, destabilise inflammasome assembly or inhibit downstream cytokines, offering promise for precision intervention in autoimmunity.

Research from Nature Portfolio

Recent studies have unveiled novel molecular pathways by which NLRP3 activation exacerbates joint inflammation and identify potential intervention points. One investigation demonstrated that elevated extracellular calcium promotes formation of calciprotein particles that are engulfed by monocytes in a calcium-sensing receptor-dependent manner, leading to lysosomal disruption, NLRP3 assembly and IL-1β release. Cells from patients with rheumatoid arthritis exhibit heightened calciprotein particle uptake and inflammasome activation, suggesting that targeting calcium-sensing receptor signalling could ameliorate joint pathology. Another study showed that oral glucosamine suppresses NLRP3-mediated inflammation by preserving mitochondrial integrity and interrupting the interaction between NLRP3 and its essential adaptor proteins. Glucosamine reduced reactive oxygen species generation, NF-κB-driven NLRP3 expression and blocked inflammasome assembly, thereby lowering IL-1β levels in vivo. These findings underscore the therapeutic potential of small-molecule or dietary approaches to stabilise mitochondrial function and disrupt inflammasome scaffolding in autoimmune contexts.

NLRP3 Inflammasome Mechanisms in Autoimmune Diseases publication trend

The graph below shows the total number of articles in nlrp3 inflammasome mechanisms in autoimmune diseases across all publications each year (not limited to Nature Index journals).

Technical terms

NLRP3 inflammasome: A cytosolic sensor complex that activates caspase-1 in response to diverse danger signals.

Pyroptosis: A lytic form of inflammatory cell death driven by gasdermin pore formation and cytokine release.

Caspase-1: An inflammatory protease that cleaves pro-IL-1β and pro-IL-18 into active cytokines.

Deubiquitinase: An enzyme removing ubiquitin chains to stabilise target proteins and modulate their activity.

Calciprotein particles: Colloidal complexes of calcium and phosphate stabilised by serum proteins that can trigger inflammasome activation.

References

1. Calcium-sensing receptor-mediated NLRP3 inflammasome response to calciprotein particles drives inflammation in rheumatoid arthritis. Nature Communications (2020).
2. Glucosamine inhibits IL-1β expression by preserving mitochondrial integrity and disrupting assembly of the NLRP3 inflammasome. Scientific Reports (2019).
3. Honokiol suppresses the aberrant interactions between renal resident macrophages and tubular epithelial cells in lupus nephritis through the NLRP3/IL-33/ST2 axis. Cell Death & Disease (2023).
4. Multi-regulatory potency of USP1 on inflammasome components promotes pyroptosis in thyroid follicular cells and contributes to the progression of Hashimoto's thyroiditis. Molecular Medicine (2024).
5. Anti-dsDNA antibodies bind to TLR4 and activate NLRP3 inflammasome in lupus monocytes/macrophages. Journal of Translational Medicine (2016).
6. NLRP3 Inflammasome: Checkpoint Connecting Innate and Adaptive Immunity in Autoimmune Diseases. Frontiers in Immunology (2021).
7. Pyroptosis and Its Role in Autoimmune Disease: A Potential Therapeutic Target. Frontiers in Immunology (2022).